tirzepatide cardiovascular outcomes trial results july 2025 โ๏ธ Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes ๐ BACKGROUND Tirzepatide, a dual incretin agonist of the glucagon-like peptide-1 and glucose-dependent Cardiovascular Outcomes in Diabetes: New
Description
Choosing the right injection timing can also help minimize sleep disruption by avoiding the most active GI side effect window during nighttime hours

Limit high-sulfur foods High-sulfur foods, like garlic, onions, and cruciferous vegetables (e.g., cabbage and cauliflower), may cause sulfur burps

Recurrent episodes require medication review

Less food means fewer opportunities to absorb B12 from dietary sources

Their website references a 6-month clinical trial of 180 participants taking semaglutide or tirzepatide alongside the WW Clinic programme (Heinberg et al.)

This could lead to disagreements with your partner and trouble in your relationship
